drugset / Trial / NCT04341077
Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects
NaSingle-groupOpen-labelOther
Summary
Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects
Timeline
- Start
- 2020-04-10
- Primary completion
- 2020-04-20
- Completion
- 2020-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzoparib | Small molecule | — | Oral |
Indications
No indication recorded.